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Bacillus cereus produces the emetic toxin cereulide, a cyclic dodecadepsipeptide that can act as a K
ionophore, dissipating the transmembrane potential in mitochondria of eukaryotic cells. Because pure cereu-
lide has not been commercially available, cereulide content in food samples has been expressed in valinomycin
equivalents, a highly similar cyclic potassium ionophore that is commercially available. This research tested
the biological activity of synthetic cereulide and validated its use as a standard in the quantification of
cereulide contents in food samples. The synthesis route consists of 10 steps that result in a high yield of
synthetic cereulide that showed biological activity in the HEp-2 cell assay and the boar sperm motility assay.
The activity is different in both methods, which may be attributed to differences in K content of the test media
used. Using cereulide or valinomycin as a standard to quantify cereulide based on liquid chromatography-mass
spectrometry (LC-MS), the concentration determined with cereulide as a standard was on average 89.9% of the
concentration determined using valinomycin as a standard. The recovery experiments using cereulide-spiked
food products and acetonitrile as extraction solute showed that the LC-MSmethod with cereulide as a standard
is a reliable and accurate method to quantify cereulide in food, because the recovery rate was close to 100% over
a wide concentration range.
The emetic type toxin cereulide is produced in food prod-
ucts, such as rice, pasta, and noodles, by cells of Bacillus cereus.
This happens during temperature abuse, and the cereulide
causes vomiting upon ingestion (9, 16). Data on the frequency
of outbreaks of emetic food poisoning are scarce, since the
symptoms are often mild and therefore not reported. One fatal
outbreak was reported in Belgium in 2003, where a child died
due to the presence of emetic toxin in pasta salad eaten during
a picnic (5). In the Netherlands an outbreak occurred in 2000,
where 116 students got ill after consumption of a rice dish
containing emetic toxin (7).
The emetic toxin, cereulide, is a cyclic dodecadepsipeptide
(D-O-Leu-D-Ala-L-O-Val-L-Val)3 (1). The toxic effects of
cereulide are caused by the ionophoric uptake of K, resulting
in dissipation of the transmembrane potential, stimulating
swelling and respiration in mitochondria, and finally resulting
in their inactivation (18). Cereulide structurally resembles va-
linomycin, another cyclic potassium ionophore (1). Both toxins
form complexes with alkali metal ions (22), but cereulide has
been suggested to have a higher toxicity than valinomycin due
to its higher affinity for potassium (23). The described effect of
cereulide on mitochondria is used in several assays to detect
the presence of cereulide in food products, like the sperm
motility inhibition assay (2, 11, 19) and the HEp-2 (human
carcinoma of the larynx) cell vacuolation assay (6, 8, 14).
Chemical assays for cereulide quantification using liquid
chromatography-mass spectrometry (LC-MS) have been de-
scribed in the literature by Ha¨ggblom et al., Bauer et al., and
Hormaza´bal et al. (4, 10, 12). This quantitative method is based
on high-performance LC (HPLC) connected to ion trap MS,
which enables very accurate detection of low cereulide concen-
trations in food and with small between-experiment variations.
For all three methods, a solution with a known concentra-
tion of cereulide is needed as an external standard in order to
quantify the cereulide level in a sample. To date, such an
external standard of cereulide could not be prepared due to
the lack of commercially available pure cereulide. As an alter-
native, the cereulide-like ionophore valinomycin has been used
as a standard, since it is commercially available in known con-
centrations and purity. The use of valinomycin as a standard
results in quantification of cereulide in terms of valinomycin
equivalents, which is an elegant method but also scientifically
debatable, since the compounds are different and might there-
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fore show different behaviors in biological and chemical assays.
In 1995 Isobe et al. (15) chemically synthesized cereulide which
was identical to cereulide produced by emetic B. cereus and
also showed biological activity.
This study describes an improved synthesis route for cereu-
lide, resulting in a higher yield and a more pure final product.
Additionally, the cereulide MS pattern was compared to that
of valinomycin by using an improved LC-MS analysis method.
The synthetic cereulide was tested for its biological activity in
both the HEp-2 cell culture assay and the boar sperm motility
assay. Finally, cereulide recovery from three cereulide-spiked
food products was evaluated using acetonitrile as the extrac-
tion medium and the LC-MS method for detection and quan-
tification, with an external standard of cereulide prepared ac-
cording to the improved protocol.
MATERIALS AND METHODS
Cereulide synthesis. The cyclic dodecadepsipeptide cereulide was synthesized
from readily available tert-butyl carbonate (Boc)-D-Ala-OH, H-L-O-Val-OBn
(where Bn is a benzyl moiety), Boc-L-Val-OH, and H-L-O-Leu-OBn (Chiralix
B.V., Nijmegen, Netherlands). First, Boc-D-Ala-OH and H-L-O-Val-OBn were
coupled to give a depsipeptide building block, which was subjected to acidolysis
of the Boc protecting group. Analogously, Boc-L-Val-OH and H-L-O-Leu-OBn
were coupled, but with inversion of the configuration of L-O-Leu, affording the
corresponding D-O-Leu-containing depsipeptide building block. This building
block was then debenzylated by hydrogenolysis. Both building blocks were sub-
jected to peptide coupling conditions to form a tetrapeptide having again N-Boc
and O-benzyl protection. Selective deprotection of this tetrapeptide resulted in
either the corresponding free amine or the free acid, followed by sequential
coupling, resulting in a linear dodecapeptide which was finally cyclized to obtain
cereulide. The complete synthesis route, including all intermediate steps, is
described in the appendix.
LC-MS analysis of synthetic cereulide and valinomycin. Ten milligrams of the
synthetic cereulide (Chiralix B.V., Nijmegen, Netherlands) was dissolved in 1 ml
methanol (Merck KGaA, Darmstadt, Germany). Solution A was obtained by
diluting this stock solution in methanol to a concentration of 50 g/ml. Solution
A was diluted in acetonitrile (Merck KGaA, Darmstadt, Germany) to a concen-
tration of 1,000 ng/ml (solution B). The working stock solution C was obtained
by diluting solution B in acetonitrile to a final concentration of 10 ng/ml. The
same procedure as described for dilution of synthetic cereulide was used for
valinomycin (Sigma-Aldrich GmbH, Steinheim, Germany) to obtain a working
stock solution of 10 ng/ml.
For both components, samples for LC-MS analysis were prepared by adding
200, 160, 120, 80, or 40 l of solution C to an LC-MS vial. The vials were filled
with additional acetonitrile to reach a total volume of 240 l to obtain a con-
centration range of solution C. Subsequently, 30 l Milli-Q water was added to
the vials, resulting in final concentrations of cereulide or valinomycin of 1.5, 3,
4.5, 6, and 7.5 ng/ml. The samples were analyzed using an LC-MS method
derived from the method described by Ha¨ggblom et al. (10). The samples were
analyzed on an ion trap LC-MS apparatus by injecting 10-l aliquots of the
samples and subsequent elution and analysis using the positive electrospray
ionization mode using either a Thermofinnigan LCQ Advantage setup (Thermo
Fisher Scientific, Waltham, MA) with a C18 column (100 mm by 2.1 mm by 5 m;
Discovery, Supelco, Bellefonte, PA) or a Thermo Scientific LTQ XL setup
(Thermo Fisher Scientific, Waltham, MA) with a C18 column (100 mm by 2.1 mm
by 5 m; Acquity UPLC, Waters Ltd., Hertfordshire, United Kingdom). The
column was eluted at a flow rate of 0.2 ml/min with the following gradient: from
0 to 18 min, 13% solution A and 87% solution B; from 18 to 35 min, 100% B;
from 35 to 50 min, 13% A and 87% B, with phase A being 2% (vol/vol)
trifluoracetic acid anhydride (TFA; Merck KGaA, Darmstadt, Germany) in
Milli-Q water with additional NH4 (added as ammonium acetate [Merck,
Darmstadt, Germany]) at a concentration of 10 mM and phase B being aceto-
nitrile. The NH4 adducts of both compounds were used for quantification (m/z
for valinomycin, 1,128.5; m/z for cereulide, 1,170.7). The peak surface of every
sample was plotted as a function of the concentration of the sample, resulting in
two calibration curves for both synthetic cereulide and valinomycin.
Natural cereulide was produced by culturing Bacillus cereus (NCTC 11143) on
tryptone soya agar (Oxoid CM 131) plates for 24 h at 28°C. After incubation the
cells were harvested by using a 10-l loop. The biomass was transferred to a
screw-cap bottle and suspended in methanol (HPLC grade; Merck 1.06007) for
extraction (10 ml methanol per g of biomass). The methanol extract was dried by
evaporation over nitrogen, and the residue was suspended in 50 ml pentane
(Merck 1.07177) and filtered over a paper filter (Schleicher & Schuell 589/3) to
trap the undissolved particles. The pentane solution was subsequently dried by
evaporation over nitrogen, and the residue was dissolved in 100 ml methanol.
This solution was used to make a calibration curve consisting of various dilutions
of natural cereulide of unknown purity (containing 1.5, 3, 4.5, 6, and 7.5 ng/ml
valinomycin equivalents). A sample of synthetic cereulide with a final concen-
tration of 4.95 ng/ml was quantified using this natural cereulide calibration curve,
with the cereulide content expressed in valinomycin equivalents.
Testing biological activity of synthetic cereulide in a HEp-2 cell assay. The
biological activity of the synthetic cereulide was determined using the HEp-2 cell
assay as described by Ehling-Schulz et al. (6). In short, Earle’s minimal essential
cell culture medium (MEM) with supplements was mixed with 2% ethanol as a
diluent, and 50 l was added to every well of a 96-well plate. Valinomycin or
cereulide was added to the first well of a row at an initial concentration of 500
ng/ml per well, and the content was serially diluted up to the 10th (valinomycin)
or the 20th (cereulide) well, respectively. The HEp-2 cells were prepared and
counted, and 150 l of the HEp-2 cell suspension was added to all wells by using
a multichannel pipette. The 96-well plates were incubated at 37°C for 48 h under
a 5% CO2 atmosphere. The cells were investigated microscopically for toxicity,
since intoxicated cells will show malformations. Subsequently, 100 l of the
liquid was removed from each well. Ten microliters of the cell proliferation
reagent WST-1 was added to every well, and the plate was incubated for 20 min
at 37°C. The absorption of every well was measured at 450/620 nm to determine
the live/dead cell ratio.
Testing biological activity of synthetic cereulide in the boar sperm motility
assay. The effect of the synthetic cereulide on boar sperm was compared to
valinomycin of known concentrations according to the modified protocol of
Rajkovic et al. (20, 21). The aliquot of the stock solution of 50 ng cereulide per
ml of methanol was evaporated under N2 and diluted in 2-fold serial dilutions to
0.78 ng/ml using dimethyl sulfoxide (DMSO; Sigma-Aldrich, Steinheim, Ger-
many) as the diluent. Volumes of 5 l of each dilution were mixed with 195 l
of sperm (from the Belgian Pie´train extramuscled boar breed; standardized to a
concentration of approximately 30 million cells per milliliter) in wells of a
microtiter plate. The mixture was immediately transferred into a 37°C pre-
warmed counting slide (standard count two-chamber 20-m slide; Leja, Nieuw-
Vennep, Netherlands). The motility behavior was observed for 10 min, and the
time to complete cessation of motility was recorded. The lowest concentration at
which motility ceased within 10 min was taken as the limit of detection. Exposure
was limited to 10 min, as any longer exposure of semen to DMSO had toxic
effects that resulted in impaired motility. Semen alone and semen mixed with 5
l of methanol served as a negative control and blank, respectively.
Extraction and detection of cereulide from food products spiked with cereu-
lide. Cooked rice, a Chinese noodle dish, and french fries were used as model
systems to test the extraction of cereulide from foods by using acetonitrile. The
samples were spiked with natural cereulide of known purity. The chosen con-
centrations of the spiked cereulide in the food product were based on the
estimated limits of quantification (1.5, 3, and 4.5 times the limit of quantification
[LOQ] for the low concentration level and 7.5, 15, and 22.5 times the limit of
quantification for the high concentration level). The low concentration level
corresponded to 6.1, 12.3, and 18.4 g cereulide/kg of sample, and the high
concentration level corresponded to 30.7, 46.1, and 92.2 g cereulide/kg of
sample. The precision of the method was determined as the standard deviation
of replicate measurements of the same sample (SDr) and standard deviation of
the replicate experiment within the same laboratory (SDRL).
Five grams of every food sample was extracted with 50 ml acetonitrile (HPLC
grade; Labscan C02C11X) by shaking it for 1 h at 100 rpm on an orbital shaker. The
sample was left to settle after shaking, and 1,000 l of the clear upper layer was
transferred to a vial. To each vial 200 l internal standard (valinomycin at a con-
centration of 25 ng/ml) and 150 l Milli-Q water (HPLC grade) were added, mixed,
and sealed. If the solution turned turbid, it was centrifuged for 10 min at10,000
g, and the clear supernatant was transferred to a new vial. The concentration of
cereulide was determined by LC-MS with the settings described above.
RESULTS
Cereulide synthesis and LC-MS analysis. The synthesis route
as described in this study (see the appendix) consists of 10 steps,
compared to 11 steps in the synthesis route reported by Isobe et
al. (15). The overall yield of this synthesis was 28.5%, a 3-fold
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improvement over the yield of the synthesis route proposed by
Isobe et al. The purity of the solution was 95%. Figures 1A to
D present the chromatogram and MS scans for, respectively,
valinomycin and synthetic cereulide. Figure 1A represents the
chromatogram (time versus relative abundance) of the valinomy-
cin NH4
 adduct, and Fig. 1C shows the cereulide NH4
 adducts.
Figure 1B shows the typical mass spectrum of the valinomycin
NH4
 adduct, and Fig. 1D shows that of the cereulide NH4

adduct. The NH4
 adducts of valinomycin and cereulide had
molecular weights of 1,128.6 and 1,170.6, respectively. The MS
scans for synthetic and natural cereulide proved to be identical
(results not shown).
Figure 2 presents the calibration curves for synthetic cereulide
and valinomycin in the concentration range of 1.5 to 7.5 ng/ml.
The results prove that the LC-MS response was linear over this
range. The difference in peak areas for equal concentrations of
the two components was 10.3%, indicating that the cereulide
content of a sample that was estimated by using valinomycin to
establish the calibration curve resulted in an overestimation of the
cereulide content by 10.3%.
FIG. 1. (A) LC chromatogram of valinomycin with elution of the compound after 7 min. (B) Full ion spectrum of valinomycin with m/z 1,128.6.
(C) LC chromatogram of cereulide with elution of the compound after 8 min. (D) Full ion spectrum of cereulide with m/z 1,170.60.
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The reverse approach, in which natural cereulide of un-
known purity was used to establish a calibration curve (cereu-
lide concentration expressed as valinomycin equivalents) and
the peak area of synthetic cereulide with a known concentra-
tion of 4.95 ng/ml was compared to the calibration curve, gave
similar results. The synthetic cereulide concentration deter-
mined was on average 5.520 ng/ml with a standard deviation of
0.205 ng/ml (n  11), 89.9% of the valinomycin concentration.
Testing the biological activity of synthetic cereulide. The
effects of various concentrations of valinomycin and cereulide
on HEp-2 cells as a function of the toxin concentration are
displayed in Fig. 3A. When the toxin concentration was above
7.81 ng/ml (cereulide) or 62.5 ng/ml (valinomycin), less than
10% of the HEp-2 cells survived the 48 h of incubation. An
increase in surviving cells was observed with a serial decrease
in toxin concentration. The toxic effect of valinomycin de-
creased faster along dilution series of equal initial concentra-
tions compared to cereulide. The 50% effective concentrations
for valinomycin and cereulide, the amounts of toxin required
to inactivate half of the cells, showed a 15-fold difference,
indicating that cereulide was 15 times more toxic to the cells
than valinomycin at an equal incubation concentration. Con-
centrations of cereulide of 1 ng/ml did not result in a measur-
able toxic effect to the cells. The effects of equal concentrations
of synthetic and natural cereulide on the HEp-2 cells were
similar (data not shown).
The effects of various concentrations of valinomycin and
cereulide on the motility of the boar sperm are represented as
a function of the toxin concentration in Fig. 3B. When the
toxin concentration was higher than 6.25 ng/ml, the boar se-
men lost their motility. A serial decrease in toxin concentration
resulted in an increase in time required to reduce semen mo-
tility. The results indicated that synthetic cereulide in the range
of 6.25 to 25 ng/ml resulted in a shorter time to complete
cessation of semen motility than with equal concentrations of
valinomycin. Although statistically significant (t test, P 0.05),
this difference was not as extensive as the difference observed
with the HEp-2 cell assay. For both compounds, concentra-
tions below 6.25 ng/ml did not result in complete cessation of
motility within 10 min. At 50 ng/ml both synthetic cereulide
and valinomycin were too toxic (complete cessation of semen
motility within a minute of exposure).
Detection of cereulide from a food product spiked with
cereulide. The results for recovery, expressed as the SDr and
the SDRL for both high and low concentrations of cereulide as
determined in the matrices cooked rice, a Chinese noodle dish,
and french fries, are presented in Table 1. The concentrations
used to determine the recovery were based on the LOQ. The
LOQ (defined as six times the background noise) was deter-
mined to be 4.1 g/kg of sample. The values for recovery
FIG. 2. Calibration curve of synthetic cereulide (black squares) and
valinomycin (gray triangles), with the peak area of the compound
measured based on LC-MS results as a function of known initial
concentrations.
FIG. 3. (A) Live HEp-2 cells, incubated with 2-fold-diluted con-
centrations of cereulide and valinomycin, as a function of nonincu-
bated HEp-2 cells. (B) Time needed for boar semen to lose motility in
the presence of 2-fold-diluted concentrations of cereulide and valino-
mycin. For both panels, white bars represent valinomycin, gray bars
represent cereulide, and black bars represent nonincubated HEp-2
cells or semen.
TABLE 1. Recovery and precision data for the quantification of
cereulide from cooked rice, a Chinese noodle
dish, and french fries
Matrix













Cooked rice 96.7 98.2 1.93 3.09 2.85 4.56
Chinese noodle dish 98.0 102.5 2.74 4.38 2.88 4.60
French fries 101.1 106.7 2.47 3.96 3.42 5.47
a Low-level samples were spiked with 6.1 to 18.4 g of cereulide/kg of sample.
b High-level samples were spiked with 30.7 to 92.2 g of cereulide/kg of
sample.
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ranged between 96.7% and 107.6%. The values for SDr and
SDRL were the lowest in cooked rice and the highest in french
fries, although the differences between the results were not
significant.
DISCUSSION
The key differences of the new synthesis route, compared to
the synthesis route described by Isobe et al., were that in the
new strategy the dipeptide building blocks were constructed by
ester bond formation and subsequent couplings of the building
blocks and that the final cyclization was achieved by amide
bond formation. In contrast, in the Isobe et al. synthesis
method the dipeptides were prepared by amide bond forma-
tion, and the subsequent couplings of the building blocks and
the final cyclization were done by ester bond formation. Since
amide bond formation is generally more facile than ester bond
formation, the new strategy resulted in a more efficient syn-
thesis, with significantly higher overall yield (10 steps with a
28.5% overall yield, compared to 11 steps with a 9.3% overall
yield with the Isobe et al. synthesis method).
The mass spectra of natural and synthetic cereulide were
identical (data not shown). Using synthesized cereulide allows
the direct determination of the concentration of cereulide in
(food) samples, instead of expressing the cereulide concentra-
tion in terms of valinomycin equivalents. Quantification of
cereulide in samples by using valinomycin as the standard
overestimated the concentration compared to that obtained
using synthetic cereulide as the standard. Using valinomycin,
the levels were approximately 10% higher. This is in corre-
spondence with observations of Ha¨ggblom et al. (10), who
found that MS results for valinomycin and cereulide are within
10%.
Both the HEp-2 cell assay and the boar sperm motility assay
proved that the synthetic cereulide is biologically active. In the
HEp-2 cell assay synthetic cereulide had a 15-fold-higher toxic
effect than valinomycin at the same concentration (Fig. 3A). In
the boar sperm motility assay this difference was of a lesser
extent (Fig. 3B). These results are in agreement with the find-
ings of Teplova et al. and Makarasen et al. (17, 23), who
suggested that the differences are caused by the different po-
tassium levels in the two assay mixtures, i.e., the boar semen
assay mixture contains 10 to 19 mM and the HEp-2 cell assay
mixture contains around 1 mM. The lower concentration of
potassium in the HEp-2 cell proliferation assay favors the
activity of cereulide, based on its higher affinity for potassium.
The current study also demonstrates that it is possible to quan-
tify cereulide in a variety of starch-rich food products at low
concentration levels (5 g cereulide/kg of sample) with good
reproducibility. The low concentration could be detected by
increasing the volume injected in the LC-MS apparatus to 20
l instead of the 1 l used by Ha¨ggblom et al. (10). In addition,
methanol was replaced by acetonitrile for extraction in order to
optimize peak shape in the LC chromatogram (data not
shown). The acetonitrile itself might also enhance the extrac-
tion of cereulide from the food, since the solvent is more
apolar than methanol (polarity indices, 5.8 versus 5.1). An
alternative approach to increase the accuracy of cereulide
quantification was recently published and is based on the ad-
dition of a 13C6 cereulide isotopologue to each sample during
extraction, dilution with water, and quantification by liquid
chromatography (4). The 13C6 cereulide isotopologue can be
considered the perfect internal standard for cereulide extrac-
tion and therefore has promising implications for further re-
search concerning cereulide extraction. On the other hand, our
study proposes extraction of cereulide with acetonitrile, with-
out dilution in water, and to increase the injection volume into
the LC-MS apparatus. This relatively simple protocol can be
applied both for research purposes and during routine analysis
of (food) samples. Commercially available cereulide may be
used as a standard of known concentration, and it can also be
considered the perfect standard for recovery and detection
experiments.
The values for recovery with the method used were good
(ranging between 96.7% and 107.6%) and were well within the
laboratory’s internal limits (acceptability range, 60 to 115% at
a level of 10 g/kg), which are based upon the AOAC peer-
verified methods program (3). The values found for SDr and
SDRL were compared to the Horwitz ratio, the index of
method performance with respect to precision, or HorRat val-
ues (13), and all values were at least three times lower than the
Horwitz values, indicating the good precision of the method.
In conclusion, this research provides a novel route for the
synthesis of biologically active cereulide, with a high yield and
purity. Recovery rates of cereulide from three tested food
matrices, using acetonitrile as extraction solvent, were close to
100%, with low SD values by LC-MS analysis. The commercial
availability of cereulide should encourage method develop-
ment for cereulide detection and quantification, since results
no longer need to be extrapolated due to the use of noniden-
tical standards.
APPENDIX
Unless noted otherwise, materials were purchased from
commercial suppliers (Sigma-Aldrich GmbH, Steinheim, Ger-
many, or Acros, Thermo Fisher Scientific, Geel, Belgium) and
used without purification. CH2Cl2 was freshly distilled from
calcium hydride. Celite was obtained from Sigma-Aldrich. All
air- and moisture-sensitive reactions were carried out under an
inert atmosphere of dry argon. Column chromatography was
performed using Acros silica gel (0.035 to 0.070 mm, 6 nm).
Thin-layer chromatography was performed using silica gel-
coated glass plates (Merck 60 F254), and compounds were
detected with UV light (254 nm) and/or with potassium per-
manganate.
Boc-(D-Ala-L-O-Val)-OBn (compound 3). DCC (N,N-dicy-
clohexylcarbodiimide) (219 mg, 1.06 mmol) was added to a
stirred solution of compound 1 (200 mg, 1.06 mmol), com-
pound 2 (208 mg, 1.00 mmol) (6), and DMAP [4-(dimethyl-
amino)pyridine] (24 mg, 0.20 mmol) in CH2Cl2 (5 ml) at 0°C.
The resulting suspension was allowed to warm to room tem-
perature and stirred for 2 h. The suspension was filtered, and
the residue was washed with CH2Cl2 (5 ml). The combined
filtrates were concentrated in vacuo. Purification by flash col-
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umn chromatography (ethyl acetate [EtOAc]/heptane, 1:4; Rf,
0.28) afforded compound 3 (330 mg, 87%) as a colorless oil.
H-(D-Ala-L-O-Val)-OBn  HCl (compound 4). A freshly pre-
pared solution of HCl(g) (i.e., added as a gas by continuous
injection in the solution) in EtOAc (2.6M, 10 ml) was added to
a stirred solution of compound 3 (317 mg, 0.83 mmol) in
EtOAc (3 ml) at room temperature. The resulting mixture was
stirred for 45 min and then concentrated in vacuo, to afford
compound 4 (261 mg, 99%) as a colorless viscous oil, which
was used without further purification.
Boc-(L-Val-D-O-Leu)-OBn (compound 7). At 0°C, triphe-
nylphosphine (976 mg, 3.72 mmol) was added to a stirred solution
of compound 5 (270 mg, 1.24 mmol) and compound 6 (276 mg,
1.24 mmol) (10) in dry tetrahydrofuran (THF) (10 ml). Next,
DEAD (diethyl azodicarboxylate) (40 wt% in toluene, 1.70 ml,
3.72 mmol) was added dropwise. The resulting yellow solution
was allowed to warm to room temperature and stirred for 1 h.
Subsequently, the mixture was concentrated in vacuo, redissolved
in EtOAc (25 ml), and washed with saturated aqueous NaHSO4
(three 10-ml volumes). The organic phase was dried over
Na2SO4, filtered, and concentrated in vacuo. Purification by flash
column chromatography (EtOAc/heptane, 1:9; Rf, 0.25) afforded
compound 7 (398 mg, 76%) as a colorless oil.
Boc-(L-Val-D-O-Leu)-OH (compound 8). Palladium on car-
bon (10% [wt/wt] Pd, 94 mg, 0.088 mmol) was added to a stirred
solution of compound 7 (371 mg, 0.88 mmol) in methanol
(MeOH; 10 ml) at room temperature. The resulting mixture was
placed under a hydrogen atmosphere and stirred vigorously for
1 h. Next, the mixture was filtered over Celite and concentrated in
vacuo to afford compound 8 (288 mg, 99%) as a colorless oil,
which was used without further purification.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val)-OBn (compound 9).
DIPEA (diisopropylethylamine) (0.30 ml, 1.7 mmol) was
added dropwise to a stirred solution of compound 8 (225 mg,
0.68 mmol) in DMF (dimethylformamide) (4 ml) at 0°C. Next,
HOBt (1-hydroxybenzotriazole) (101 mg, 0.75 mmol) and EDCI
[N-(3-dimethylaminopropyl)-N-ethylcarbodiimide] (144 mg,
0.75 mmol) were added successively. Finally, a solution of
compound 4 (225 mg, 0.71 mmol) in DMF (2 ml) was added
dropwise. The resulting mixture was allowed to warm to room
temperature and stirred for 16 h. Next, the mixture was diluted
with EtOAc (30 ml). The organic phase was washed with aque-
ous citric acid (10% [wt/wt], two times with 5 ml), water (once
with 5 ml), saturated aqueous NaHCO3 (two times with 5 ml),
water (once with 5 ml), and brine (once with 5 ml), dried over
Na2SO4, filtered, and concentrated in vacuo. Purification by
flash column chromatography (EtOAc/heptane, 1:3; Rf, 0.23)
afforded compound 9 (250 mg, 62%) as a colorless oil.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val)-OH (compound 10).
Palladium on carbon (10% [wt/wt] Pd, 13 mg, 0.01 mmol) was
added to a stirred solution of compound 9 (72 mg, 0.12 mmol)
in MeOH (3 ml) at room temperature. The resulting mixture
was placed under a hydrogen atmosphere and stirred vigor-
ously for 1 h. Next, the mixture was filtered over Celite and
concentrated in vacuo to afford compound 10 (61 mg, 99%) as
a white solid, which was used without further purification.
H-(L-Val-D-O-Leu-D-Ala-L-O-Val)-OBn  HCl (compound
11). A freshly prepared solution of HCl(g) in EtOAc (2.6 M, 4
ml) was added to a stirred solution of compound 9 (125 mg,
0.21 mmol) in EtOAc (1 ml) at room temperature. The result-
ing mixture was stirred for 45 min and then concentrated in
vacuo to obtain compound 11 (106 mg, 95%) as a colorless
viscous oil, which was used without further purification.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val-L-Val-D-O-Leu-D-Ala-L-
O-Val)-OBn (compound 12). DIPEA (34 l, 0.19 mmol) was
added to a stirred solution of compound 10 (44 mg, 0.088
mmol) in CH2Cl2 (2 ml) at room temperature, followed by
addition to a solution of compound 11 (48 mg, 0.091 mmol) in
CH2Cl2 (1 ml). Finally, PyBop [(benzotriazol-1-yloxy)tripyr-
rolidinophosphonium] (48 mg, 0.092 mmol) was added, and
the mixture was stirred for 40 min. Next, the mixture was
diluted with EtOAc (15 ml). The organic phase was washed
with aqueous citric acid (10% [wt/wt], twice with 5 ml), water
(once with 5 ml), saturated aqueous NaHCO3 (twice with 5
ml), water (once with 5 ml), and brine (once with 5 ml), dried
over Na2SO4, filtered, and concentrated in vacuo. Purification
by flash column chromatography (EtOAc/heptane, 1:2; Rf,
0.23) afforded compound 12 (79 mg, 92%) as a white solid.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val-L-Val-D-O-Leu-D-Ala-L-
O-Val)-OH (compound 13). Palladium on carbon (10% [wt/wt]
Pd, 8 mg, 0.007 mmol) was added to a stirred solution of 12 (72
mg, 0.074 mmol) in MeOH (2 ml) at room temperature. The
resulting mixture was placed under a hydrogen atmosphere and
stirred vigorously for 1 h. Next, the mixture was filtered over
Celite and concentrated in vacuo to obtain compound 13 (65 mg,
99%) as a white solid, which was used without further purifica-
tion.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val-L-Val-D-O-Leu-D-Ala-L-
O-Val-L-Val-D-O-Leu-D-Ala-L-O-Val)-OBn (compound 14). DI-
PEA (26 l, 0.15 mmol) was added to a stirred solution of com-
pound 13 (59 mg, 0.067 mmol) in CH2Cl2 (1.5 ml) at room
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temperature, followed by a solution of compound 11 (36 mg,
0.068 mmol) in CH2Cl2 (0.75 ml). Finally, PyBop (37 mg, 0.70
mmol) was added, and the mixture was stirred for 1 h. Next, the
mixture was diluted with EtOAc (15 ml). The organic phase was
washed with aqueous citric acid (10% [wt/wt], twice with 5 ml),
water (once with 5 ml), saturated aqueous NaHCO3 (twice with 5
ml), water (once with 5 ml), and brine (once with 5 ml), dried over
Na2SO4, filtered, and concentrated in vacuo. Purification by flash
column chromatography (EtOAc/heptane, 2:3; Rf, 0.26) afforded
compound 14 (87 mg, 96%) as a white solid.
Boc-(L-Val-D-O-Leu-D-Ala-L-O-Val-L-Val-D-O-Leu-D-Ala-L-
O-Val-L-Val-D-O-Leu-D-Ala-L-O-Val)-OH (compound 15). Pal-
ladium on carbon (10% [wt/wt] Pd, 6 mg, 0.005 mmol) was added
to a stirred solution of compound 14 (78 mg, 0.057 mmol) in
MeOH (2.5 ml) at room temperature. The resulting mixture was
placed under a hydrogen atmosphere and stirred vigorously for
1 h. Next, the mixture was filtered over Celite and concentrated in
vacuo to afford compound 15 (72 mg, 100%) as a white solid,
which was used without further purification.
H-(L-Val-D-O-Leu-D-Ala-L-O-Val-L-Val-D-O-Leu-D-Ala-L-
O-Val-L-Val-D-O-Leu-D-Ala-L-O-Val)-OH  HCl (compound
16). A freshly prepared solution of HCl(g) in EtOAc (2.6 M, 4
ml) was added to a stirred solution of compound 15 (66 mg,
0.052 mmol) in EtOAc (1 ml) at room temperature. The re-
sulting mixture was stirred for 45 min and then concentrated in
vacuo, to obtain compound 16 (61 mg, 98%) as a white solid,
which was used without further purification.
Cereulide. DIPEA (22 l, 0.12 mmol) was added to a stirred
solution of compound 16 (50 mg, 0.041 mmol) in DMF (40 ml)
at room temperature, followed by PyBop (23 mg, 0.043 mmol),
and the mixture was stirred for 16 h. Next, the mixture was
diluted with EtOAc (200 ml). The organic phase was washed
with aqueous citric acid (10% [wt/wt]; twice with 50 ml), water
(once with 50 ml), saturated aqueous NaHCO3 (twice with 50
ml), water (once with 50 ml), and brine (once with 50 ml),
dried over Na2SO4, filtered, and concentrated in vacuo. Puri-
fication by flash column chromatography (EtOAc/heptane, 1:3;
Rf, 0.28) afforded cereulide (34 mg, 72%) as a white solid.
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